We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 10.82%
3 Consumer Discretionary 10.62%
4 Healthcare 9.9%
5 Industrials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MASS icon
2651
908 Devices
MASS
$422M
$23K ﹤0.01%
587
RJET
2652
Republic Airways Holdings
RJET
$959M
$23K ﹤0.01%
166
MUC icon
2653
BlackRock MuniHoldings California Quality Fund
MUC
$1.02B
$23K ﹤0.01%
1,501
-2,650
-64% -$41K
PBYI icon
2654
Puma Biotechnology
PBYI
$447M
$23K ﹤0.01%
2,522
PKOH icon
2655
Park-Ohio Holdings
PKOH
$704M
$23K ﹤0.01%
726
PVBC
2656
DELISTED
Provident Bancorp
PVBC
$23K ﹤0.01%
1,419
VOE icon
2657
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
$23K ﹤0.01%
167
+76
+84% +$10.7K
ITI
2658
DELISTED
Iteris, Inc.
ITI
$23K ﹤0.01%
3,527
GRTS
2659
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$23K ﹤0.01%
2,546
CDAK
2660
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$23K ﹤0.01%
1,231
+766
+165% +$14.7K
NBEV
2661
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$23K ﹤0.01%
10,439
+4,058
+64% +$9.46K
STFC
2662
DELISTED
State Auto Financial Corp
STFC
$23K ﹤0.01%
1,338
AQB icon
2663
AquaBounty Technologies
AQB
$7.98M
$22K ﹤0.01%
+206
New +$23.6K
BHR
2664
Braemar Hotels & Resorts
BHR
$140M
$22K ﹤0.01%
+3,489
New +$21.5K
BNED icon
2665
Barnes & Noble Education
BNED
$420M
$22K ﹤0.01%
+30
New +$24.2K
BNTX icon
2666
BioNTech
BNTX
$23.1B
$22K ﹤0.01%
100
CNTY icon
2667
Century Casinos
CNTY
$35.5M
$22K ﹤0.01%
1,662
EQWL icon
2668
Invesco S&P 100 Equal Weight ETF
EQWL
$2.8B
$22K ﹤0.01%
281
IJS icon
2669
iShares S&P Small-Cap 600 Value ETF
IJS
$8.45B
$22K ﹤0.01%
210
LMNR icon
2670
Limoneira
LMNR
$253M
$22K ﹤0.01%
1,228
LITS
2671
Lite Strategy Inc
LITS
$30.8M
$22K ﹤0.01%
383
NRIM icon
2672
Northrim BanCorp
NRIM
$605M
$22K ﹤0.01%
2,100
PGX icon
2673
Invesco Preferred ETF
PGX
$3.77B
$22K ﹤0.01%
1,439
-449
-24% -$6.79K
PRLD icon
2674
Prelude Therapeutics
PRLD
$444M
$22K ﹤0.01%
769
RUSHB icon
2675
Rush Enterprises Class B
RUSHB
$9.35B
$22K ﹤0.01%
846

Similar funds

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.